Power Laws

Power Laws During the 1930s, Kleiber1 put forward a "law"--more correctly, an empirical generalization--stating that standard metabolic rate is proportional to the three-quarters power of body mass. The recent resurgence of interest in the phenomenon caught the attention of Philip Hunter.2 The West model,3-5 which explains that Kleiber's Law features prominently in the resurgence, and Hunter does this model considerable justice in explaining it for the nonspecialist. However, Hunter's arti

Written byDenys Wheatley
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

During the 1930s, Kleiber1 put forward a "law"--more correctly, an empirical generalization--stating that standard metabolic rate is proportional to the three-quarters power of body mass. The recent resurgence of interest in the phenomenon caught the attention of Philip Hunter.2

The West model,3-5 which explains that Kleiber's Law features prominently in the resurgence, and Hunter does this model considerable justice in explaining it for the nonspecialist. However, Hunter's article implies that the West model is the only explanation currently on the table, and in being uncritical, it fails to mention the possibility that the model might be flawed.

And what of the several alternative models, such as Banavar's6 and Darveau's?7 An article about the allometric scaling of metabolic rate that discusses only one of the several current models inevitably gives a distorted picture.

In our view (and that of other biologists), not one of the extant models is flawless. What is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies